Scientists Crack 40-Year Mystery of Sleeping Sickness Parasite

After 40 years of mystery, scientists have finally figured out how the parasite causing sleeping sickness manages to stay invisible inside the human body.

Researchers at the University of York discovered a protein called ESB2 that acts like a molecular shredder, allowing the African trypanosome parasite to destroy specific genetic instructions while they're being made. This lets the parasite fine-tune its protective "cloak" with surgical precision, dodging detection by our immune system.

The parasite wears a coat made of proteins to hide in human blood. Scientists knew the genetic instructions for this coat also contained "helper genes" the parasite needs to survive. But here's what baffled them: the parasite produces tons of coat proteins but barely any helper proteins, even though logic says it should make equal amounts of both.

Dr. Joana Faria and her international team cracked the case. The ESB2 protein sits inside the parasite's protein factory and acts as a blade, instantly shredding the helper sections while leaving the cloak instructions untouched. It's like having an editor who deletes parts of a document in real time as it's being printed.

"We've discovered that the parasite's secret to staying invisible isn't just what it prints, but what it chooses to redact," said Dr. Faria, who leads the research team. The discovery marks the first major breakthrough from her new lab at York.

Sleeping sickness, transmitted by tsetse fly bites, remains a devastating disease across sub-Saharan Africa. Without treatment, the parasites invade the nervous system, causing severe sleep disruptions, confusion, and coma.

The Ripple Effect

This breakthrough does more than solve an old puzzle. By understanding exactly how the parasite controls its disguise, researchers can now spot new weak points in its survival strategy. Those vulnerabilities could lead to treatments that save lives across an entire region.

The project brought together scientists from six countries including the UK, Portugal, Netherlands, Germany, Singapore, and Brazil. "When we first saw the molecular shredder localized in the microscope, we knew we had found something special," said first author Lianne Lansink.

For Dr. Faria, the discovery feels personal. "The mystery has been a cold case in the back of my mind since my days as a postdoc," she said. "To finally solve it now is incredibly rewarding."

The research appears in Nature Microbiology and represents a major step forward for York's growing reputation as a global life sciences hub. Sometimes the best solutions come from looking at old problems with fresh eyes and a diverse team of brilliant minds.